Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Tekirdağ
Clinical trial register · Turkey

Clinical Trials in Tekirdağ, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Tekirdağ

29 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Namik Kemal University
Not applicable
50
Tekirdağ
2026-10-01
Recruiting
Namik Kemal University
Not applicable
60
Tekirdağ
2026-08-01
Recruiting
Gülsev Kutman
Not applicable
164
Tekirdağ
2026-06-15
Recruiting
Namik Kemal University
Not applicable
108
Tekirdağ
2026-05-04
Recruiting
Istanbul Saglik Bilimleri University
Not applicable
64
Tekirdağ
2026-05-01
Not yet open
Non-Invasive Ventilation Interfaces and Nasal Pressure Injury in Preterm Infants
NCT07521410Medical Device-Related Pressure Injury, Prematurity
Istanbul University - Cerrahpasa
Not applicable
75
Tekirdağ
2026-04-20
By invitation
Nursing Education Provided After Cesarean Section Surgery.
NCT07467304Cesarean Birth, Patient Education
Namik Kemal University
Not applicable
80
Tekirdağ
2025-12-01
By invitation
Gagne Learning Model in Nursing Education
NCT07348549Nursing Education, Learning Process in Nursing Graduation, Learning Techniques
Namik Kemal University
Not applicable
68
Tekirdağ
2025-12-01
By invitation
Flipped Learning in Nursing Education
NCT07349862Nursing Students, Education, Flipped Education Model
Namik Kemal University
Not applicable
60
Tekirdağ
2025-12-01
Recruiting
Namik Kemal University
Not applicable
80
Tekirdağ
2025-05-27
By invitation
Occlutech International AB
Observational
200
Izmir, Ankara, Istanbul, Tekirdağ, Bursa, Kocaeli
2025-02-05
Active, closed
mAbxience Research S.L.
Phase 3
726
Adana, Alanya, Ankara, Istanbul, Izmir, Sakarya, Samsun, Tekirdağ
2024-12-30
Recruiting
Namik Kemal University
Observational
1,000
Tekirdağ
2024-12-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Sıhhiye, Adapazarı, Tekirdağ, Adana, Ankara, Istanbul, Kayseri, Trabzon
2024-10-21
Recruiting
Namik Kemal University
Not applicable
150
Tekirdağ
2024-10-01
Active, closed
BioNTech SE
Phase 2
110
Adana, Ankara, Gaziantep, Istanbul, Izmir, Kocaeli, Sakarya, Tekirdağ
2024-08-05
Active, closed
Regeneron Pharmaceuticals
Phase 3
216
Mamak, Ankara, Mezitli, Tekirdağ, Istanbul, Izmir, Sakarya, Samsun
2024-02-15
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Mamak, Yenimahalle, Ankara, Mezitli, Tekirdağ, Istanbul, Izmir, Sakarya
2023-12-28
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Yenimahalle, Mezitli, Tekirdağ, Ankara, Istanbul, Izmir, Sakarya, Samsun
2023-12-13
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Mamak, Yenimahalle, Ankara, Mezitli, Sakarya, Tekirdağ, Istanbul, Kayseri
2023-11-14
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Ascentage Pharma Group Inc.
Phase 3
350
Ankara, Antalya, Istanbul, Izmir, Kayseri, Mersin, Samsun, Tekirdağ
2023-08-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
Bornova, Tekirdağ, Ankara, Istanbul
2023-08-08
Active, closed
argenx
Phase 3
173
Adapazarı, Ankara, Izmir, Kocaeli, Mersin, Tekirdağ, Trabzon
2021-11-17
By invitation
Namik Kemal University
Not applicable
321
Tekirdağ
2021-06-15
Active, closed
Genmab
Phase 3
483
Ankara, Istanbul, Izmir, Tekirdağ, Trabzon
2021-01-13
Recruiting
Occlutech International AB
Observational
150
Ankara, Elâzığ, Erzincan, Fatih, Izmir, Kocaeli, Tekirdağ
2020-10-28
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/tekirda

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Tekirdağ.

How many clinical trials are recruiting in Tekirdağ?

15 of the 29 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 7 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Tekirdağ), 29 studies
PhaseStudiesRecruitingShare
Phase 313744.8%
Not applicable12641.4%
Observational3210.3%
Phase 2103.4%

Most active sponsors

Lead sponsors with the most studies (Tekirdağ)
Lead sponsorStudiesRecruiting
Namik Kemal University105
Regeneron Pharmaceuticals53
Merck Sharp & Dohme LLC22
Occlutech International AB21
argenx10
Ascentage Pharma Group Inc.11
BeOne Medicines10
BioNTech SE10
Genmab10
Gülsev Kutman11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.